Immunocore Holdings plc
Biotechnology company · Abingdon, England, United Kingdom · Nasdaq: IMCR
Immunocore Holdings plc is a biotechnology company headquartered in Abingdon, England, United Kingdom. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker IMCR. It has reported private securities offerings to the US SEC, most recently $140 million sold in a notice filed in 2022. It is registered with UK Companies House under company number 13119746.
Immunocore Holdings at a glance
What does Immunocore Holdings do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $140 million sold (2022).
Frequently asked questions about Immunocore Holdings
Where is Immunocore Holdings headquartered?
Immunocore Holdings plc is headquartered in Abingdon, England, United Kingdom.
What does Immunocore Holdings do?
Immunocore Holdings plc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Immunocore Holdings a public company?
Yes. Immunocore Holdings plc trades on Nasdaq under the ticker IMCR.
When was Immunocore Holdings founded?
The earliest incorporation on record for Immunocore Holdings plc is in 2021, according to public company registers.
Similar companies
- Adaptimmune Therapeutics PLCAbingdon, England, United Kingdom
- binx health LtdTrowbridge, England, United Kingdom
- Calcivis LtdEdinburgh, Scotland, United Kingdom
- Orchard Therapeutics plcLondon, England, United Kingdom
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Contains public sector information licensed under the Open Government Licence v3.0 (UK Companies House).
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.